3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
5
Thoracic
1
Sarcoma
1
Head & Neck
1
Conditions
Carcinoma, Non-Small-Cell Lung
895
Lung Neoplasms
610
Small Cell Lung Carcinoma
167
Colorectal Neoplasms
126
Breast Neoplasms
107
Melanoma
106
Neoplasms
93
Ovarian Neoplasms
92
Neoplasm Metastasis
87
Pancreatic Neoplasms
73
Squamous Cell Carcinoma of Head and Neck
68
Stomach Neoplasms
57
Carcinoma, Renal Cell
56
Head and Neck Neoplasms
54
Endometrial Neoplasms
50
Triple Negative Breast Neoplasms
49
Esophageal Neoplasms
49
Prostatic Neoplasms
46
Uterine Cervical Neoplasms
42
Urinary Bladder Neoplasms
40
Colonic Neoplasms
40
Mesothelioma
39
Mesothelioma, Malignant
36
Carcinoma, Hepatocellular
36
Brain Neoplasms
33
Sarcoma
29
Carcinoma, Transitional Cell
28
Adenocarcinoma of Lung
27
Lung Diseases
26
Disease
25
Interventions
pralsetinib
1
pembrolizumab
1
Pemetrexed
1
Paclitaxel
1
Gemcitabine
1
Cisplatin
1
Carboplatin
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms, Nerve Tissue
×
Thoracic
×
90 days
×
Clear all
NCT04222972
2026-03-05
AcceleRET-Lung
Hoffmann-La Roche
Phase 3
Terminated
223 enrolled
18 charts